drugset / Trial / NCT01004237

Additive Effects of Pravastatin and Valsartan

NCT01004237

Phase 4 Completed 52 enrolled Gachon University Gil Medical Center
RandomizedCrossoverSingle-blindTreatment

Summary

The investigators hypothesize that pravastatin combined with valsartan may have additive effects in hypertensive, hypercholesterolemic patients.

Timeline

Start
2009-11
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pravastatin Small molecule 40 mg
Comparator Valsartan Small molecule 160 mg

Indications